Back to Search
Start Over
Cangrelor use in a 6-year-old patient undergoing complex percutaneous coronary intervention after post-surgical myocardial infarction
- Source :
- Platelets. 31(8)
- Publication Year :
- 2020
-
Abstract
- Cangrelor is an intravenously administered P2Y12 receptor antagonist, which has been approved for adult patients undergoing percutaneous coronary intervention and, due to its unique pharmacokinetic...
- Subjects :
- 0301 basic medicine
Male
medicine.medical_specialty
Post surgical
P2Y12 Receptor Antagonists
medicine.medical_treatment
Myocardial Infarction
030204 cardiovascular system & hematology
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Cangrelor
Percutaneous Coronary Intervention
Pharmacokinetics
Internal medicine
medicine
Humans
Myocardial infarction
Adult patients
business.industry
Percutaneous coronary intervention
Hematology
General Medicine
medicine.disease
Adenosine Monophosphate
030104 developmental biology
chemistry
Conventional PCI
Cardiology
business
Subjects
Details
- ISSN :
- 13691635
- Volume :
- 31
- Issue :
- 8
- Database :
- OpenAIRE
- Journal :
- Platelets
- Accession number :
- edsair.doi.dedup.....c9b9bdb751ab247202cc4cd128760d9d